C
CC icon

Cerebellum’s Chemours CC Stock Holding History

Cerebellum’s Portfolio CC Stock Details CC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-1,490
Closed -$75K – 415
2020
Q2 		$75K Buy
+1,490
New +$18.8K 0.05% 388
2019
Q3 		– Sell
-717
Closed -$17K – 436
2019
Q2 		$17K Buy
+717
New +$21.1K 0.01% 397
2018
Q4 		– Sell
-248
Closed -$10K – 457
2018
Q3 		$10K Sell
248
-3,690
-94% -$161K 0.02% 374
2018
Q2 		$175K Buy
+3,938
New +$196K 0.29% 149
2018
Q1 		– Sell
-1,490
Closed -$75K – 458
2017
Q4 		$75K Buy
+1,490
New +$78K 0.05% 388

Other funds holding CC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
GC
Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return

Cerebellum's CC Position: Q3 2020 in Review

Cerebellum sold out of Chemours (CC) in Q3 2020, closing a stake of 1,490 shares — an estimated $75K sold.

Cerebellum first reported a position in CC in Q4 2017 and held it in 5 quarters. The position peaked at $175K in Q2 2018. 384 funds tracked by Wall St. Rank hold CC as of Q3 2020.

  • Cerebellum reported no remaining Chemours position as of Q3 2020 after selling out during the quarter.
  • Cerebellum sold 1,490 Chemours shares in Q3 2020, an estimated $75K.
  • Cerebellum first reported a position in Chemours in Q4 2017 and held it in 5 quarters.
  • Cerebellum's Chemours position peaked at $175K in Q2 2018.
  • 384 funds tracked by Wall St. Rank held Chemours as of Q3 2020.

Based on Cerebellum's 13F filing for Q3 2020, filed 21 Oct 2020.